Be The First To
Corcept Therapeutics wants to help people who are beyond blue. The biotechnology firm is exploring treatments that regulate the presence of Cortisol, a steroid hormone associated with some psychiatric and metabolic disorders. It is developing its lead candidate Corlux, a version of the compound mifepristone (commonly known as RU-486 or the "abortion pill"), as a means to regulate release patterns of cortisol in patients with psychotic depression, as well as those experiencing weight gain from taking other antipsychotic medications. The company is also investigating whether...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
CEO and Director
Pros: The salaries are very competitive, even high compared to other pharmaceutical companies. CEO is warm, communicative and the employees like and respect him. – Full Review
Let us know if we're missing any workplace or industry recognition –